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Background: Non-melanoma skin cancer (NMSC) is one of the most common neoplasms in the world. Despite the
low mortality rates, NMSC can still cause severe sequelae when diagnosed at advanced stages. Malignant
melanoma, the third most common type of skin cancer, has more aggressive behavior and a worse prognosis.
Teledermatology provides a new tool for monitoring skin cancer, especially in countries with a large area and
unequal population distribution.
This study sought to evaluate the performance of digital photography in skin cancer diagnosis in remote areas of Brazil.
Methods: A physician in a Mobile Prevention Unit (MPU) took four hundred sixteen digital images of suspicious lesions
between April 2010 and July 2011. All of the photographs were electronically sent to two oncologists at Barretos
Cancer Hospital who blindly evaluated the images and provided a diagnosis (benign or malignant). The absolute
agreement rates between the diagnoses made by direct visual inspection (by the MPU physician) and through the use
of digital imaging (by the two oncologists) were calculated. The oncologists’ accuracy in predicting skin cancer using
digital imaging was assessed by means of overall accuracy (correct classification rate), sensitivity, specificity and
predictive value (positive and negative). A skin biopsy was considered the gold standard.
Results: Oncologist #1 classified 59 lesions as benign with the digital images, while oncologist #2 classified 27 lesions
as benign using the same images. The absolute agreement rates with direct visual inspection were 85.8% for
oncologist #1 (95% CI: 77.1-95.2) and 93.5% for oncologist #2 (95% CI: 84.5-100.0). The overall accuracy of the two
oncologists did not differ significantly.
Conclusions: Given the high sensitivity and PPV, Teledermatology seems to be a suitable tool for skin cancer screening
by MPU in remote areas of Brazil.
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Skin cancer is the most common malignancy in many
parts of the world, including Brazil [1,2]. More than 2
million new non-melanoma skin cancer (NMSC) cases
are diagnosed in the United States each year [3], and ap-
proximately 76,250 new cases of malignant melanoma
were expected to be diagnosed in 2012 [4]. However, the
true incidence of NMSC remains unknown because
these lesions are not commonly reported to cancer* Correspondence: cegsilveira@gmail.com
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unless otherwise stated.registries. It has been estimated that 25% of all new can-
cer cases diagnosed in Brazil in 2012 will be skin can-
cers, with approximately 134,170 new cases of NMSC and
6,230 malignant melanomas expected to be identified.
These numbers represent an approximately 16% increase
in new NMSC cases and a 4% increase in melanomas
compared with 4 years ago [1].
Despite a low mortality rate, NMSC can still cause se-
vere sequelae when diagnosed at advanced stages [5] be-
cause these lesions occur predominantly on sun-exposed
areas such as the face, which can become disfigured.
Moreover, significant morbidity costs may occur [6]. Ma-
lignant melanoma, the third most common type of skinThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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nosis, causing a significant decrease in life expectancy
and lost productivity [6].
Currently, the best method for the early detection of
skin cancer is to identify changes in skin lesions, includ-
ing the appearance of new growths [4]. However, this
strategy is not easily implemented in developing coun-
tries due to a shortage of trained professionals and their
availability in remote areas. For example, in the State of
São Paulo, which has the largest cancer registry in Brazil,
9% of basal cell cancer (BCC) cases, 21% of squamous
cell cancer (SCC) cases and 49% of malignant melano-
mas are diagnosed at stages II, III or IV [7].
Teledermatology provides a new tool for monitoring
skin cancer in countries such as Brazil, which has a large
area and an unequal population distribution. Telederma-
tology essentially involves sending digital images to spe-
cialized cancer centers for evaluation by trained experts
[8-10] and provides a platform for professional training
programs and physicians to discuss complex cases without
the necessity of transporting patients, which may lead to
substantial savings in time and cost [11]. This approach
also effectively reduces the waiting times for surgical treat-
ment [12] and facilitates the spread of dermatological
knowledge into poor regions of the world [13].
Because of the high incidence of skin cancer in Brazil,
the difficulty accessing doctors in poor areas and the lack
of studies on teledermatology in developing countries, we
decided to utilize the existing telecommunication technol-
ogy and evaluate the accuracy of digital imaging in diag-
nosing skin cancer in remote areas of Brazil.
Methods
Patients
The skin cancer screening was performed by a Mobile
Prevention Unit (MPU) of Barretos Cancer Hospital
(BCH). The MPU regularly visits the remote areas of
Brazil, including the states of Mato Grosso, Mato Grosso
do Sul and Rondônia, screening the local people for
prostate, cervical and skin cancers. The MPU trailer is
fully equipped to perform clinical procedures and ambu-
latory surgeries. The MPU team consists of a physician,
a nurse, three nurse technicians and a driver. This team
is able to perform 40 clinical dermatology examinations
or procedures per day, including cryotherapy and sur-
gery. All of the patients examined at the MPU were pre-
viously screened by a nurse from the local municipality
who was trained at BCH. A more detailed description of
the MPU concept has been published elsewhere [14].
The present study included individuals with skin le-
sions that were determined to be suspicious after a dir-
ect visual inspection by a physician between April 2010
and July 2011. These patients were evaluated in the
MPU, and their lesions were photographed (digitalimaging). All of the lesions suspected to be malignant by
the MPU physician were biopsied and/or excised after pho-
tography and submitted to the Department of Pathology at
BCH for histological evaluation. The Institutional Review
Board (IRB) at BCH previously approved the research
protocol (No. 377/2010). All of the subjects signed an in-
formed consent agreement.Methods
The lesions were photographed by the MPU physician
using a Sony Cybershot DSC-5780 digital camera with
8.1-megapixel resolution. One digital image of each le-
sion was taken at a distance of 60 cm to evaluate the le-
sion topography, with an additional image taken at a
shorter distance (using the macro mode) to evaluate the
lesion details.
Pertinent information such as age, skin complexion,
location of the lesion, stage and pathology results were
collected and used for the TNM Classification of Malig-
nant Tumors (AJCC) system, 7th edition [15]. All of the
diagnoses were classified according to the International
Classification of Diseases (ICD-10). We used the Skin
Type (or complexion) Classification System proposed by
Fitzpatrick, which utilizes the Skin Type 1–6 scale where
1 denotes pale white skin, 2 denotes white skin, 3 de-
notes light brown skin, 4 denotes moderate brown skin,
5 denotes dark brown skin and 6 denotes pigmented
dark brown to black skin [16].
All of the digital images were coded, stored and sub-
mitted at random to two oncologists at BCH. These two
experts were blinded to the MPU physician’s diagnosis
and pathology reports, and classified the images using
the following options: 1) a malignant lesion, oncological
treatment is indicated; 2) a benign lesion, no treatment
required; 3) unknown; or 4) a low-quality image. Both
the oncologists and the MPU physician have more than
10-years of experience in skin cancer screening.Statistical analysis
The diagnoses made by all three physicians were charac-
terized by descriptive statistics using SPSS for Windows
software (v. 17.0, SPSS Inc., Chicago, IL, USA). The ab-
solute agreement rates between the diagnoses obtained
from direct visual inspection (by the MPU physician) and
through the use of digital images (by the two oncologists)
were calculated. The oncologists’ performance in predict-
ing skin cancer using the digital images was evaluated on
the basis of overall accuracy (correct classification rate),
sensitivity, specificity, positive predictive value (PPV) and
negative predictive value (NPV). The result of a skin bi-
opsy was considered the gold standard. Confidence inter-
vals (95% CI) were calculated whenever appropriate.
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A total of 2,592 patients underwent dermatological
examination at the MPU throughout the duration of the
study. Of these, 460 (17.7%) had a suspicious lesion that
was classified as possibly malignant by the MPU phys-
ician. These lesions were imaged, biopsied/removed and
submitted for histopathological examination at BCH. Of
the 460 patients, 21 (4.6%) were excluded from the study
because of poor quality photos, leaving 439 patients with
pathological results. Of these 439 lesions, 23 (5.2%) were
excluded because of incomplete data preventing the
identification of the patient, while 364 (87.5%) were con-
firmed to be malignant by the biopsy. The majority of
the lesions were BCCs (78.5%), and most were located in
the head and neck area (75%). A large majority of the le-
sions (93%) were classified as stages 0 and I (Table 1).
These patients had a mean age of 63.5 years (range: 19
to 93 years) and were from 5 states of Brazil (MT, MS,
RO, GO and MG). The patients were predominantly
(81%) light-skinned, i.e., skin type 1 or 2 (Table 1).
Altogether, 416 digital images were electronically sent
the two oncologists, who completely blinded by any clin-
ical description or attached information. The oncologists
classified the tumors in the images as either malignant
or benign. Oncologist #1 classified 59 lesions as benign
using the digital images, while oncologist #2 classified 27
lesions as benign using the same images., The absolute
agreement rates with the direct visual inspection wereTable 1 Diagnosis and location of the biopsied or
removed lesions and skin complexion of the patients
Variable Category N (%)
Pathology* Basal cell carcinoma 286 (78.5)
Squamous cell carcinoma 59 (16.2)
Melanoma 5 (1.4)
Other** 14 (3.8)
Site Head and Neck 273 (75.0)
Trunk 28 (7.6)
Upper limbs 61 (16.7)
Lower limbs 2 (0.5)





Skin type scale 1-2 295 (81)
3-4 69 (19)
5-6 0 (0)
*52 lesions were confirmed to be benign by the biopsy; **Bowen’s disease,
malignant trichoepithelioma and metatypical carcinoma; ***51 patients were
not staged because they did not go to BCH for diagnostic follow-up.85.8% for oncologist #1 (95% CI: 77.1-95.2) and 93.5%
for oncologist #2 (95% CI: 84.5-100.0) (Table 2). These
rates were not statistically different.
Table 3 summarizes the oncologists’ performance in
predicting skin cancer using the digital images. The
overall accuracy, specificity and predictive values (nega-
tive and positive) did not differ significantly between the
two oncologists; however, oncologist #2 had a slightly,
but significant, higher sensitivity.
Discussion
The most remote areas of Brazil are located North of
the Tropic of Capricorn and near the Equator—areas
where solar radiation is very intense [17]. Since the
1980s, these regions have received large numbers of mi-
grants from the Southern and Midwestern regions of
Brazil, where people are predominantly of European des-
cent. Thus, the majority of these inhabitants have light
skin. Not surprisingly, this migration has increased the
incidence of skin cancer in this area [1]. Despite this in-
crease, the Brazilian government is reluctant to invest in
permanent programs for skin cancer prevention because
of the existing controversy over whether or not screen-
ing increases the survival of melanoma patients [18].
Developing countries exhibit an unequal distribution
of doctors throughout their territories. In Brazil, the
concentration of physicians is higher in metropolitan
areas, and there is a huge gap in the availability of these
professionals in remote areas [19]. Brazil averages one
doctor for every 551 inhabitants [20], with this number
varying from one doctor for every 232 inhabitants in the
city of São Paulo to one doctor for every 10,000 inhabi-
tants in some remote areas of the Amazon States and
Rondônia [20,21]. This situation is further exacerbated
when medical experts, such as dermatologists, are sought.
In this case, there may be one dermatologist for every
90,000 inhabitants in certain regions of Brazil [21,22].
Given this reality, one alternative is teledermatology,
which is being promoted worldwide as an effective toolTable 2 Number and percentage of lesions, as





N (%) N (%)
MPU physician Malignant 364 (87.5) 52 (12.5) 416
Benign - - -
Oncologist #1 Malignant 325 (91.0) 32 (9.0) 367
Benign 39 (66.1) 20 (33.9) 59
Oncologist #2 Malignant 350 (90.0) 39 (10.0) 389
Benign 14 (51.9) 13 (48.1) 27
MPU =mobile prevention unit.
Table 3 Oncologists’ performance indicators in predicting
skin malignancy using digital imaging
Oncologist #1 Oncologist #2
% (95% CI) % (95% CI)
Sensitivity 89.3 (85.7-92.3) 96.2 (93.6-97.9)
Specificity 38.5 (25.3-53.0) 25.0 (14.0-39.0)
Positive predictive value 91.0 (87.6-93.8) 90.0 (86.6-92.8)
Negative predictive value 33.9 (22.1-47.4) 48.2 (26.7-68.1)
Overall accuracy 85.3 (76.7-94.7) 87.3 (78.5-96.7)
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method reduces the waiting times for these patients and
results in good customer satisfaction scores [23,24], satis-
factory clinical results [25] and good cost-effectiveness
[26]. Despite the fact that teledermatology has been recog-
nized as an important skin cancer screening tool in even
large populations [27], few studies have investigated the
use of teledermatology for diagnosing skin cancer [28,29].
This technique could be particularly useful in developing
countries [13], where skin cancer predominantly presents
in the clinic at advanced stages. To our knowledge, this is
the first study to use mobile units for teledermatology.
The present study was a store-and-forward telederma-
tology study used for skin cancer screening. The study
was performed using an MPU in which a physician ex-
amined a large number of patients who were referred
because of a suspected skin cancer lesion. These patients
were subjected to a biopsy and/or lesion removal for
histopathological confirmation. Thus, the present study
represents a typical screening setting, where a positive
test (classification as suspicious by digital image) was
verified by the gold standard (skin biopsy). This study
showed a high rate of agreement between the MPU phy-
sician’s diagnosis by visual inspection and the diagnosis
given by the two oncologists using the digital images as
a diagnostic tool. This result is quite impressive given
the fact that oncologists #1 and #2 performed their ana-
lysis in a tertiary cancer hospital (BCH) up to 1,200
miles away from the MPU. These concordance values
are even more impressive if one also considers that some
of this variability may be due to differences in data inter-
pretation between the physicians and the different expe-
riences of the physicians involved and not due to the
technology itself [13]. It seems that the physician’s ex-
perience in skin cancer screening may be more import-
ant than the technology, a finding that is not surprising.
Previous reports have found that inter-observer agree-
ment varies significantly depending on case selection,
the use of classification criteria [30] and the level of ex-
pertise of the physicians [13,28]. Thus, the high level of
concordance between the oncologists in this study mayalso be related to the fact that they have more than
10 years of experience in skin cancer screening in Brazil.
When the diagnoses of the physicians were translated
to performance indicators of digital imaging, the crude
sensitivity for oncologist #1 was 89.3% and the crude
sensitivity for oncologist #2 was even higher at 96.2%
(Table 3). The PPV was equally high for both physicians,
but the specificity and NPV were not particularly im-
pressive. It must be emphasized that these calculations
are based on incomplete evaluations [31], as biopsy veri-
fication was only performed for test-positive cases, i.e.,
the digital images classified as malignant. This situation
occurred because it would be unethical to perform a bi-
opsy on normal skin tissue. For any type of screening,
the optimal test is the one with the highest PPV [31]. In
this respect, the teledermatology setting tested here
seems to be a highly suitable screening tool.
From the clinical point of view, the type of lesions
missed by this screening approach is important; for ex-
ample, missing a malignant melanoma is more serious
than missing a BCC or SCC, which exhibit a substan-
tially more protracted clinical course. According to our
histological records, there were 5 histologically-
confirmed malignant melanomas in the present series.
Of those malignancies, observer 1 diagnosed 1/5 cor-
rectly, while observer 2 correctly diagnosed 3/5 cases.
This result would justify using dermatoscopy to screen
all pigmented lesions. However, this practice is not feas-
ible in large countries with limited resources in rural
areas, such as Brazil. A dermatoscope is an expensive
piece of equipment, and the proper use of this technique
necessitates the practical training of the physicians, pre-
cluding the use of this instrument in population-based
screening for skin cancer.
Digital image diagnosis approach seems to be a viable
option for teledermatology settings that utilize MPUs.
One limitation of this study is the fact that we were not
able to capture images from a camera attached to a der-
matoscope, which is known to further increase diagnos-
tic precision [32-34]. We only used a simple digital
camera, which is easier for any health professional to
handle than a more complex device such as a dermato-
scope. Another limitation was the lack of clinical histor-
ies for the examined patients (work in agriculture,
family history of skin cancer, etc.) and a description of
the characteristics of the lesion (raised or flat, lesion
size, time of development, etc.) to assist the observing
physicians in making the final diagnoses.
Despite the limitations of this study, the high number
of evaluated lesions and the high concordance between
the observers clearly indicate that teledermatology
could be used as an effective tool to screen for malig-
nant skin lesions, especially in the remote areas of de-
veloping countries.
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This study showed high agreement between direct visual
inspection and digital imaging in identifying suspicious
skin lesions. Moreover, digital imaging played a previously
unrecognized role in predicting skin cancer. Hence, this
study suggests that it is feasible to use digital imaging as a
tool to screen for skin cancer in a population-based setting
and that this approach would be particularly useful in
remote areas.
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